Mechanisms and Functional Significance of Stroke-Induced Neurogenesis by Quentin Marlier et al.
REVIEW
published: 08 December 2015
doi: 10.3389/fnins.2015.00458






Consiglio Nazionale delle Ricerche,
Italy
John W. Cave,





This article was submitted to
Neurogenesis,
a section of the journal
Frontiers in Neuroscience
Received: 15 October 2015
Accepted: 16 November 2015
Published: 08 December 2015
Citation:
Marlier Q, Verteneuil S,
Vandenbosch R and Malgrange B
(2015) Mechanisms and Functional
Significance of Stroke-Induced





Quentin Marlier, Sebastien Verteneuil, Renaud Vandenbosch and Brigitte Malgrange*
GIGA-Neurosciences, University of Liege, C.H.U. Sart Tilman, Liege, Belgium
Stroke affects one in every six people worldwide, and is the leading cause of adult
disability. After stroke, some limited spontaneous recovery occurs, the mechanisms
of which remain largely unknown. Multiple, parallel approaches are being investigated
to develop neuroprotective, reparative and regenerative strategies for the treatment of
stroke. For years, clinical studies have tried to use exogenous cell therapy as a means
of brain repair, with varying success. Since the rediscovery of adult neurogenesis and
the identification of adult neural stem cells in the late nineties, one promising field of
investigation is focused upon triggering and stimulating this self-repair system to replace
the neurons lost following brain injury. For instance, it is has been demonstrated that the
adult brain has the capacity to produce large numbers of new neurons in response to
stroke. The purpose of this review is to provide an updated overview of stroke-induced
adult neurogenesis, from a cellular and molecular perspective, to its impact on brain
repair and functional recovery.
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INTRODUCTION
Stroke is the second leading cause of death, the most common cause of adult-acquired disability
and affects one in every six people worldwide (Moskowitz et al., 2010). The number of people
who survive a stroke is increasing, and with an aging population, the incidence and prevalence
of stroke are predicted to rise even more (Sun et al., 2012). Despite years of research, effective
treatments remain elusive. Currently, the only proven therapy for acute ischemic stroke is systemic
thrombolysis with recombinant tissue plasminogen activator (rtPA). To be effective, rtPA must
be administered within a maximum of 4.5 h after the symptoms first start. This short timeframe
and potential adverse effects have limited the use of rtPA to 3–5% of stroke patients (Ruan et al.,
2015). Grafting stem cells represents a compelling alternative and offers both a wide array and an
unlimited supply of cells. Indeed, the transplantation of neural stem cells (NSCs), mesenchymal
stem cells (MSCs), embryonic stem cells (ESCs), or induced pluripotent stem cells (iPSCs) could
be used to replace neuronal loss after stroke (Kalladka and Muir, 2014). However, exogenous stem
cell therapy has both technical and ethical issues. For instance, cell survival and migration rely
heavily on the timing and mode of delivery (Li et al., 2010; Darsalia et al., 2011). Moreover, surgical
procedure and toxicity (as cancer induction) increase the complexity of transplanted cell therapies
(Kawai et al., 2010; Ben-David and Benvenisty, 2011). Finally, some ethical issues may arise from
the use of fetal/embryonic cells.
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Despite the fact that the central nervous system (CNS) has
a limited repair capacity (Nakagomi et al., 2011), some degree
of spontaneous recovery from brain ischemia invariably occurs
(Yu et al., 2014). This repair process involves neurogenesis,
angiogenesis, and axonal sprouting and synaptogenesis. Here we
concentrate on the events that are associated with the production
of new neurons and not the mechanisms that involve the
reorganization of connectivity among surviving neurons, which
is reviewed elsewhere (Jones and Adkins, 2015).
Recent experimental findings have raised the possibility
that functional improvement after stroke may be induced
through neuronal replacement by endogenous NSCs. Indeed,
the original dogma that no new neurons are formed after birth
has been definitively overturned during the past few decades.
The discovery of the thymidine analog bromodeoxyuridine
(BrdU)—that incorporates into DNA in S-phase and can be
detected by immunohistochemistry—has allowed researchers to
conclusively demonstrate the generation of new neurons in the
brain of all adult mammals including humans (Eriksson et al.,
1998; Gage, 2000). This production of new neurons in the adult
brain—so-called adult neurogenesis—takes place in areas called
neurogenic niches. The subventricular zone (SVZ) of the lateral
ventricle and the subgranular zone (SGZ) of the dentate gyrus
(DG) are the two main neurogenic niches containing adult NSCs
that proliferate, divide and differentiate into mature neurons.
Recently, new evidence have highlighted that adult neurogenesis
could also takes place in other brain areas, along the ventricular
system, mostly in pathological conditions (Lin and Iacovitti,
2015).
The capacity to produce new neurons in the adult brain and
the ability of the ischemia-injured adult brain to partially recover
suggest a possible relationship between adult neurogenesis and
stroke recovery. Indeed, many studies have shown an increase
in cell proliferation in the rodent SVZ following ischemic
injury (Thored et al., 2006), and evidence for stroke-induced
neurogenesis in the human brain has also been reported (Jin
et al., 2006). In addition, endogenous brain repair is not limited
to neurogenic niches. Recent studies have shown that glial
cells surrounding the infarct core can be reactivated following
ischemia. Indeed, pericytes, oligodendrocyte precursors, and
astrocytes are all able to differentiate into neurons following brain
injury (Robel et al., 2011; Heinrich et al., 2014; Nakagomi et al.,
2015; Torper et al., 2015). Moreover, surviving neurons may
reorganize their connections in a manner that supports some
degree of spontaneous improvement. Therefore, a promising
field of investigation is focused on triggering and stimulating this
self-repair system to replace dead neurons following an ischemic
attack.
STROKE PATHOPHYSIOLOGY
Stroke, also known as cerebrovascular accident, results from a
transient or permanent reduction in cerebral blood flow that
is restricted to the territory of a major brain artery (Woodruff
et al., 2011). The two main types of stroke are hemorrhagic
stroke (15%) due to bleeding and ischemic stroke (85%) due
to lack of blood flow. The three main mechanisms causing
ischemic stroke are thrombosis, embolism and global ischemia
(Hossmann, 2012). In all of these cases, decreased or absent
circulating blood deprives neurons of their necessary substrates,
leading irrevocably to cell death. Although different brain
regions have varying thresholds for ischemic cell damage, and
certain populations of neurons are selectively more resistant
to ischemia, neurons are by far the most sensitive cells, ahead
of oligodendrocytes, astrocytes, and vascular cells (Woodruff
et al., 2011). Despite the fact that neurological dysfunction
occurs within seconds to minutes after decreased perfusion, the
evolution of ischemic injury continues for several hours and even
days (Moskowitz et al., 2010), leading to massive neuronal death
and corresponding patient disabilities.
Acute occlusion of a major brain artery leads to spatially and
temporally stereotyped events, including morphological damage
that evolves over a prolonged period and which depends on
the topography, severity and duration of ischemia (Hossmann,
2012). Two specific areas of damage can be defined. The first
area is the rapidly formed “ischemic core,” which corresponds
to the irreversibly damaged tissue close to the occluded artery
(Yuan, 2009). It is characterized by a <20% of baseline blood
flow levels, below the energy metabolism threshold (Lo, 2008).
In this area, neurons are deprived of their two main supplies:
glucose and oxygen. Without these two factors, neurons are
unable to produce the ATP needed to maintain ionic gradients.
This energy deficit also induces the activation of voltage-
gated calcium (Ca2+) channels. As a consequence, an increase
in intracellular Ca2+ concentration is observed, leading to
the activation of phospholipases and proteases, which degrade
membranes and proteins essential for cell integrity. Moreover,
this massive accumulation of Ca2+ is passively followed by
water, causing intracellular edema and cell swelling (Iadecola
and Anrather, 2011). Unless blood flow is quickly restored,
necrotic and irreversible cell death will consequently occur within
minutes or a few hours. The second area is the “ischemic
penumbra,” a region of moderately perfused tissue surrounding
the ischemic core, where oxygen is still present to irrigate
neurons thanks to collateral arteries. In this area, the reduction
of blood flow is not sufficient to cause energy failure and disrupt
ionic gradients. Consequently, neurons remain viable but are
stressed and vulnerable. Excessive extracellular accumulation
of glutamate is a major factor contributing to cell death
in the ischemic penumbra zone. The resulting overactivation
of glutamate receptor channels of the N-methyl-D-aspartate
(NMDA) subtype leads to cytoplasmic accumulation of Ca2+,
which activates Ca2+-dependent enzymes, including calpains
and caspases, and finally leads to apoptotic cell death (Iadecola
and Anrather, 2011). Moreover, during ischemia, mitochondria
generate reactive oxygen species (ROS), which modulate signal
transduction cascades that tip the balance between pro-death and
pro-survival pathways, or act directly as executioners of cell death
(Moskowitz et al., 2010). The importance of cell death in the
ischemic penumbra area depends upon residual cerebral blood
flow (CBF). If CBF is not re-established rapidly, the neurons
will die after a few hours or days. The ischemic penumbra
represents a salvageable brain area, in which neuronal activity
is suppressed but the tissue is potentially viable (Moskowitz
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et al., 2010). Therefore, early reperfusion is the major target of
most therapeutic and experimental interventions in an attempt
to reestablish sufficient CBF and rescue cells in the penumbra.
In addition to the above-mentioned histological features,
focal ischemia leads to a robust inflammatory response that
begins within a few hours. Early on, the production of
cytokines by vascular cells and perivascular microglia exposed
to ischemic insult contribute to the inflammatory response.
Indeed, activated microglia produce toxic metabolites such
as ROS and nitric oxide (NO), as well as pro-inflammatory
mediators such as IL-6, matrix metalloproteinases (MMPs) and
toll-like receptors, which contribute to extend brain injury
(Schilling et al., 2003; del Zoppo et al., 2007; Okun et al.,
2009). Although activated microglia and vascular cells appear
detrimental to cell survival and recovery at the beginning
of the insult, chronically activated microglia may, however,
secrete beneficial factors that enhance tissue repair (Moskowitz
et al., 2010). Reactive astrocytes also have a biphasic role
regarding the inflammatory response to stroke. They can extend
ischemic lesions by producing pro-inflammatory cytokines
(del Zoppo et al., 2000), but also possess a neuroprotective
role, through the release of erythropoietin, which leads to
the phosphorylation and subsequent inactivation of the pro-
apoptotic protein BAD (Ruscher et al., 2002; Prass et al., 2003).
This could be of importance regarding spontaneous recovery
and regulation of stroke-induced neurogenesis, as discussed
below.
THERAPEUTIC STRATEGIES FOR STROKE
The development of therapeutic strategies aimed at overcoming
neuronal loss, especially by avoiding delayed neuronal death
in penumbra or by replacing dead cells in the ischemic core,
is essential. Despite significant improvements after systemic
thrombolysis using rtPA, only a small number of patients
have timely access to this therapy. As an alternative, the most
encouraging approach is stem cell therapy, by using exogenous
stem cell grafts or stimulating endogenous stem cell proliferation
and differentiation into cells of interest.
Exogenous Stem Cells
Cell replacement for stroke requires the regeneration of multiple
functionally specialized cell types, including different kind
of neurons, glial and endothelial cells, to restore the entire
neurovascular unit (Kalladka and Muir, 2014). Grafting cells into
the CNS represents a promising avenue for cell replacement
therapies. Grafted cells could potentially differentiate into specific
cell subtypes and functionally integrate into the host circuitry
in order to repopulate damaged areas. Different sources of stem
cells have been proposed to treat stroke and include NSCs, ESCs,
iPSCs, and MSCs (Table 1).
NSCs are self-renewing, multipotent cells with the ability
to proliferate and give rise to neurons, astrocytes and
oligodendrocytes, in vitro and in vivo. They can be derived from
ESCs or iPSCs, but also directly from adult stem cells located and
isolated from different tissues, such as skin or blood (Anderson,
2001; Morrison, 2001). Recently, transplantation of NSCs from
the adult murine brain in ischemic rats led to cell migration
to ischemic regions and significant behavioral improvements
compared to non-transplanted animals, althoughmany cells died
early after transplantation (Chu et al., 2005; Jiang et al., 2006;
Zhang and Chopp, 2009; Darsalia et al., 2011; Song et al., 2011).
Cell survival and behavior is strongly influenced by the timing
and mode of their delivery. For example, intraparenchymal
transplantation decreases sensorimotor dysfunctions and motor
deficits, while intracerebroventricular injection does not result
in any improvement (Smith et al., 2012). Moreover, upon
intravenous transplantation of adult mouse NSCs after stroke,
only a few percent of cells survive in the brain (Bacigaluppi
et al., 2009). Importantly, exogenous stem cell therapy could
enhance the endogenous self-repair system. Indeed, transplanted
human NSCs, by releasing several factors such as vascular
endothelial growth factor (VEGF), neurotrophins or fibroblast
growth factor-2 (FGF-2), are highly effective in stimulating
endogenous neurogenesis in rats when cells are delivered directly
into the ischemic brain parenchyma (Sun et al., 2003; Türeyen
et al., 2005; Drago et al., 2013). Finally, this improved endogenous
neurogenesis is accompanied by modulation of the inflammatory
response. Transplantation of adult NSCs induces a down-
regulation of pro-inflammatory mediators, such as interferon-γ
(IFN-γ), tumor necrosis factor alpha (TNF-α) and interleukin-
1β (IL-1β) in ischemic mice brains (Bacigaluppi et al., 2009). This
drastically decreases the microglia driven inflammatory response
(Oki et al., 2012) and therefore host-driven repair (Martino and
Pluchino, 2006; Martino et al., 2011; Kokaia et al., 2012).
ESCs are pluripotent cells derived from the inner cell mass
of blastocysts. The major advantage of ESCs is that a large
number of cells can be expanded in culture and differentiated
in any neuronal subtype. However, major ethical (embryos
destruction) and scientific (immune-compatibility, teratoma
formation) issues must be overcome before using them in
clinical practice (Ben-David and Benvenisty, 2011). The recently
discovered human iPSCs avoid the ethical issues of ESCs
by generating autologous patient-specific cells. Unfortunately,
iPSCs share the tumorigenicity characteristics found in ESCs
(Ben-David and Benvenisty, 2011). Indeed, when iPSCs are
delivered through intracerebroventricular (ICV) injection into
an ischemic rat brain, large teratomas form, and there is little
behavioral improvement compared with PBS-implanted controls
rats (Kawai et al., 2010). However, new neuroblasts and mature
neurons have been observed in the ischemic area, revealing a
direct differentiation of iPSCs (Kawai et al., 2010). Following
in vitro pre-differentiation of iPSCs into neuroepithelial-like stem
cells, no tumors were found and improvements in function,
a reduced infarct size and differentiated neuronal cells were
reported (Jiang et al., 2011; Oki et al., 2012; Yuan et al., 2013;
Eckert et al., 2015). These data indicate that iPSCs are another
source of stem cells—beside adult NSCs—able to improve stroke
recovery.
Among the different stem cell types that are candidates
for grafting after stroke, MSCs represent the most promising
candidates. Transplantation experiments with MSCs derived
from different species (rats, mice, rabbit, or human) and using
different routes of administration have been performed (Chen
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TABLE 1 | Summary of exogenous stem cells types and their role in stroke recovery.
NSC ESC iPSC MSC
Origin • ESC
• iPSC





• Bone marrow stromal cells




• ST • ST • IV
• ST
Behavior • Proliferate, migrate and differentiate into
neurons
• Stimulate endogenous stem cell
proliferation





• Migrate into ischemic area
• Modulate inflammatory
response





• Promote functional recovery




• No ethical, moral and
legal issues
• Facility to acquire
• No ethical issue










References Anderson, 2001; Chu et al., 2005; Jiang
et al., 2006; Martino and Pluchino, 2006;
Bacigaluppi et al., 2009; Zhang and Chopp,
2009; Barkho and Zhao, 2011; Darsalia et al.,
2011; Martino et al., 2011; Song et al., 2011;
Hassani et al., 2012; Kokaia et al., 2012; Oki
et al., 2012; Jensen et al., 2013; Mine et al.,
2013; Hermann et al., 2014; Tang et al., 2014
Bühnemann et al.,




Kawai et al., 2010;
Ben-David and
Benvenisty, 2011;
Jiang et al., 2011; Oki
et al., 2012; Jensen
et al., 2013
Li et al., 2000; Chen et al.,
2001a,b; Chen et al., 2008;
Kang et al., 2003; Kurozumi
et al., 2005; Honma et al., 2006;
Horita et al., 2006; Cui et al.,
2007; Andrews et al., 2008; Koh
et al., 2008; Bao et al., 2011,
2013; Gutiérrez-Fernández et al.,
2011; Braun et al., 2012; Ruan
et al., 2013; Wang et al., 2014;
Lee et al., 2015
ESC, embryonic stem cells; IA, intra-arterial; ICV, intracerebroventricular; iPSC, induce-pluripotent stem cells; IV, intravenous; MSC, mesenchymal stem cells; NSC, neural stem cells;
ST, stereotaxic.
et al., 2001a,b; Horita et al., 2006; Cui et al., 2007; Gutiérrez-
Fernández et al., 2011; Braun et al., 2012; Ruan et al., 2013).
Stereotaxic (ST) transplantation of adult MSCs directly into the
adult brain significantly reduces the functional deficit associated
with stroke (Li et al., 2000; Kang et al., 2003; Horita et al.,
2006). Moreover, significant reductions in infarct volume, as
well as improvements in functional outcomes have also been
observed following intravenous (IV) delivery ofMSCs in a rodent
model of stroke (Kurozumi et al., 2005; Honma et al., 2006; Koh
et al., 2008). The mechanisms underlying the beneficial effects of
MSCs are multifactorial. MSCs secrete numerous growth factors
and cytokines that are neurotrophic, enhance revascularization
and exhibit immunomodulatory properties as well as enhancing
host neurotrophic factor expression, host neurogenesis and cell
replacement (Kurozumi et al., 2005; Andrews et al., 2008; Bao
et al., 2011, 2013). However, the contribution of grafted cells
to the replacement of lost neurons is still unclear (Chen et al.,
2001a,b). The efficacy of MSC grafts is largely time-dependent.
Indeed, earlier MSC transplantations are associated with better
functional recovery after stroke (Lee et al., 2015). This may be
linked to the decreased inflammatory processes and the secretion
of trophic factors by MSCs that reduce cellular apoptosis in the
early period of stroke (Wang et al., 2014).
Altogether, stem cell graft experiments have highlighted
promising potential strategies regarding stroke recovery, by
either directly replacing lost neurons or more importantly, by
helping endogenous proliferation and modulating inflammation.
Endogenous Stem Cells
Even without any treatment, some degree of spontaneous
recovery occurs after brain injury. Recent findings have shed
light on the possibility that therapeutic outcomes after stroke
may originate from endogenous NSCs residing in the adult
brain, such as in the SVZ and the SGZ. Adult neurogenesis
occurring in these areas could participate in the replacement
of neurons lost following ischemia. Importantly, stroke induces
cell proliferation in these specific areas, but also in other parts
of the brain. These new neurogenic zones could potentially
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represent a “reservoir” of endogenous cells able to increase
their proliferation after ischemic injury in order to repopulate
damaged parenchyma. However, not much is known about the
mechanisms underlying stroke-induced neurogenesis, in terms of
cellular origin, molecular regulation or functional integration.
Localization
A basal rate of proliferation is present in the SVZ, SGZ
and hypothalamus of the healthy adult mammalian brain.
Therefore, the first experiments performed regarding stroke-
induced neurogenesis have tried to determine from which part of
the brain stroke-activated endogenous stem cells may come from.
Classical neurogenic niches: SGZ&SVZ
If endogenous stroke-induced neurogenesis occurs, the two
most likely areas where it may happen are the two classical
neurogenic niches SGZ and SVZ. In the hippocampus, NSCs—
also named type-1 radial glia-like cells—are found in the SGZ,
at the interface of the hilus and the granular cell layer (GCL).
These cells divide slowly and give rise to type-2 cells or transit-
amplifying progenitors, which divide actively to generate type-3
cells or neuroblasts. Neuroblasts exit the cell cycle and migrate
a short distance into the GCL where they differentiate into
immature postmitotic neurons. Around 50% of the immature
neurons produced will die, and only a few newborn granule
cells will be stably integrated into the synaptic network of the
DG (Genin et al., 2014). This adult hippocampal neurogenesis is
likely implicated in cognitive processes such as learning, memory,
and cognition. Experimental models of cerebral ischemia are
categorized as global or focal. In models of global ischemia, in
which CBF is reduced throughout most of the brain, a 10-fold
increase in SGZ progenitor proliferation has been demonstrated
in many species, such as gerbils, rats, mice, monkeys as well as
humans (Imai et al., 2007; Wiltrout et al., 2007). Focal ischemia
models, which are more frequently used, consist of a temporary
occlusion of the middle cerebral artery (MCAO) that produces
infarcts in the ipsilateral area of the cerebral cortex and striatum
(Ginsberg and Busto, 1989). In these models, studies have also
reported a significantly enhanced proliferation of NSCs and
progenitors in the SGZ (Yagita et al., 2001; Sharp et al., 2002;
Wiltrout et al., 2007). Generally, the increased proliferation starts
bilaterally at 3–4 days post-ischemia (Lichtenwalner and Parent,
2006), peaks at 7–10 days and returns to control levels by 3–5
weeks (Arvidsson et al., 2002; Takasawa et al., 2002; Dempsey
et al., 2003; Zhu et al., 2003). One week after the ischemic episode,
a 2–3-fold increase of cell production is observed in the DG
as compared to the basal level seen in control animals. Over
60% of these cells express Calbindin—a calcium-binding protein
normally expressed in mature granule neurons—5 weeks after
the ischemia (Kee et al., 2001). Altogether, these data indicate
that SGZ is likely to be one source of the endogenous stem cells
responding to stroke.
The SVZ lies adjacent to the lateral ventricles along the
lateral wall. It is composed of different types of NSCs classified
by their self-renewal and differentiation capacities. Radial glial
NSCs—the so-called type B cells—extend an apical ending that
is exposed to the ventricle and possess a long basal process
ending on blood vessels (Mirzadeh et al., 2010). These cells are
surrounded by multiple ependymal cells (type E cells) forming
pinwheel structures on the ventricle surface (Mirzadeh et al.,
2008). Type B cells divide slowly to generate transit-amplifying
type C cells, which proliferate actively and further differentiate
into neuroblasts also named type A cells. Finally, these cells
form chains and migrate over long distances toward the olfactory
bulb (OB), via the rostral migratory stream (RMS). In the OB,
neuroblasts migrate radially and differentiate into granule cells
or periglomerular interneurons (Carleton et al., 2003).
There are numerous studies demonstrating that stroke
stimulates SVZ NSCs proliferation and neurogenesis (Arvidsson
et al., 2002; Kokaia and Lindvall, 2003; Thored et al., 2006). Some
have demonstrated a post-MCAO activation of SVZ NSCs in
rats (Jin et al., 2001; Zhang et al., 2001, 2004, 2007; Li et al.,
2002; Parent et al., 2002), mice (Carlén et al., 2009; Zhang
et al., 2014) and even monkeys (Tonchev et al., 2005) with an
increase in proliferationmarkers that peaks at day 14 post-stroke.
Beside this increased proliferation, it has been shown that these
SVZ NSCs are migrating, differentiating and integrating into
the lesion site tissue in rodent MCAO models (Zhang et al.,
2001; Parent et al., 2002; Yamashita et al., 2006; Magnusson
et al., 2014). Indeed, many BrdU+/NeuN+ cells were found in
the post-ischemic striatum brain (Arvidsson et al., 2002) and a
fluorescent tracing of SVZ proliferating cells showed that these
cells directly migrate from the SVZ to the striatum in the post-
ischemic rat brain (Jin et al., 2003). Ischemia may induce these
newly generated neural precursors of the SVZ to revoke their
normal migratory pattern, and instead to migrate toward the
injured areas of the brain and aid in spontaneous recovery
(Thored et al., 2006). Moreover, besides stroke-induced NSCs
proliferation, non-proliferative type E cells have been shown to
also be able to generate neuroblasts and astrocytes following
ischemic injury (Carlén et al., 2009).
Novel neurogenic niches
Recent evidence suggests that, in addition to the canonical SGZ
and SVZ, other stem cell niches are present in the adult brain.
Indeed, the presence of adult NSCs has been proven in rodent
hypothalamus (Kokoeva et al., 2005; Xu et al., 2005; Migaud et al.,
2010; Pérez-Martín et al., 2010; Pierce and Xu, 2010) and also
in the striatum of rats (Dayer et al., 2005), mice (Shapiro et al.,
2009), rabbits (Luzzati et al., 2006), and monkeys (Bédard et al.,
2006). Evidence for adult neurogenesis has also been shown in
certain neocortical areas of the adult rat (Dayer et al., 2005),
mouse (Shapiro et al., 2009) and monkey brain (Bernier et al.,
2002). Finally, amygdala neurogenesis has been demonstrated
in mice (Shapiro et al., 2009), rabbits (Luzzati et al., 2006), and
monkeys (Bernier et al., 2002) as well as brainstem neurogenesis
in rat (Bauer et al., 2005).
Hypothalamus. The most described new stem cell niche is the
hypothalamus. Proliferating cells found in the hypothalamus
can be divided in two groups. The first one is located
in the lateral wall of the third ventricle at the level of
paraventricular, ventromedial and arcuate nuclei (Hypothalamic
Ventricular Zone, HVZ, Figure 1). The second group, formed
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FIGURE 1 | Cellular origin of stroke-induced neurogenesis. (A) In the healthy brain, adult neural stem cells are found to proliferate in the SGZ of the DG, in the
SVZ along the lateral ventricle (green) and the HVZ and HPZ along the third ventricle (red). (B) In the ischemic brain, proliferating adult neural stem cells are found
along the third ventricle, the fourth ventricle (4V) and the CVOs (SFO, OVLT, Subcommissural organ, area postrema) (Red) as well as directly in the ischemic
parenchyma (orange), besides classical neurogenic niches (Lin and Iacovitti, 2015). HVZ, hypothalamic ventricular zone; HPZ, hypothalamic proliferating zone; CVOs,
Circumventricular organs; SFO, subfornical organ; OVLT, organum vasculosum of the lamina terminalis.
by tanycytes—a specialized ependymal cell type—is located
at the bottom of the third ventricle in median eminence
region and called the hypothalamic proliferating zone (HPZ).
Physiologically, hypothalamic neurogenesis seems to play a role
in energy balance; however, the rate of proliferation is much
less than in the two canonical neurogenic niches (Rojczyk-
Golebiewska et al., 2014). Nevertheless, tanycytes that form the
rat and humanHVZ express classical markers of neural precursor
cells such as nestin (Wei et al., 2002) and doublecortin-like
protein, a microtubule-associated protein highly homologous
to doublecortin (DCX), a marker of neuroblasts and immature
neurons, in the adult mouse brain (Saaltink et al., 2012).
Importantly, proliferation of NSCs is enhanced on the ischemia
ipsilateral side along the third ventricle (Lin et al., 2015).
Ventricular system: windows of the brain. Besides the SVZ and
the median eminence, recent studies suggest that NSCs are also
present at other circumventricular brain regions, particularly
the sensory “circumventricular organs” (CVOs; Bennett et al.,
2009; Furube et al., 2015). The sensory CVOs are the organum
vasculosum of the lamina terminalis (OVLT), the subfornical
organ (SFO), the pineal gland (PG), the subcommissural organ
(SCO), and the area postrema (AP). The sensory CVOs, located
outside the blood-brain barrier, are involved in the maintenance
of a wide variety of sensory homeostatic and inflammatory
pathways in the brain (Joly et al., 2007; Price et al., 2008). In vivo
studies have revealed that CVOs cells proliferate and undergo
constitutive neurogenesis and gliogenesis (Bennett et al., 2009).
In addition to CVOs, proliferating cells are also found along the
fourth ventricle (4V) (Lin et al., 2015). Consistent with these
findings, neurospheres have been generated in vitro from isolated
CVO and 4V cells (Bauer et al., 2005; Charrier et al., 2006; Itokazu
et al., 2006).
Adult CVOs stem cells residing in a subventricular location
incorporate BrdU and express the proliferation marker Ki67, as
well as stem cells markers such as nestin and Sox2, as is the case
in the SVZ (Bennett et al., 2009). Moreover, these cells are able
to generate new neurons in vivo. Indeed, some proliferating cells
found in CVOs were also positive for TUC-4 (TOAD (Turned
On After Division)/Ulip/CRMP-4), a very early neuronal marker,
and the mature neuronal marker NeuN (109). More importantly,
in response to stroke in rats, an increased proliferation of NSCs
in the CVOs as well as along the 4V has been observed. Similarly,
proliferating cells are also observed in CVOs after stroke in
humans (Sanin et al., 2013). CVO and 4V cells—like classical
NSCs—are able to differentiate into oligodendrocytes, astrocytes,
and neurons following stroke (Lin and Iacovitti, 2015) even if
a shift toward neurogenesis was observed (Bennett et al., 2009).
Interestingly, some newborn cells coming from novel neurogenic
niches have been observed in a chain formation potentially
migrating away from these novel niches to the infarct core (Lin
et al., 2015). Taken together, the CVO reservoir of stem cells may
serve as a further source of NSCs in humans for recovery after
stroke.
Non-neurogenic niches
The increased proliferation and migration of endogenous stem
cells in the neurogenic niches contributes to stroke-induced
neurogenesis, and provides a clear link between stroke and
neurogenesis. However, not only neurogenic niches must be
taken into account regarding stroke-induced neurogenesis.
Accumulating evidence suggests that ischemic injury induces
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the generation of new neurons from activated NSCs directly
in the cerebral cortex (Magavi et al., 2000; Jiang et al., 2001;
Jin et al., 2006; Yang et al., 2007). These ischemia-induced
NSCs generate nestin-positive neurospheres in vitro. Following
stroke, these nestin-positive cells develop in the ischemic
subpial region, in proximity to blood vessels, and spread
into the cortex through cortical layer 1 (Ohira et al., 2010;
Nakagomi et al., 2011). These progenitor cells may originate from
microvascular pericytes, as they express pericyte markers such as
platelet-derived growth factor receptor β (PDGFRβ) and NG2
(Nakagomi et al., 2015). Indeed, new evidence has highlighted
the multipotential differentiation capacity of vascular pericytes
(PCs). PCs extracted from ischemic regions from the mouse or
human brain and cultured under oxygen/glucose deprivation
have developed stem cell-like features, presumably through
reprogramming (Nakagomi et al., 2015). Moreover, cells from the
adult human cerebral cortex that express PC markers, such as
PDGFRβ and NG2, have been reprogrammed into neuronal cells
by retrovirus-mediated co-expression of Sox2 andMash1 (Karow
et al., 2012). These induced-neuronal cells acquire the ability
to fire repetitive action potentials and serve as synaptic targets
for pre-existing neurons, indicating their capacity to integrate
into neural networks. Taken together, these data show that PCs
constitute a promising source of NSCs that can be activated
following stroke and aid the replacement of dead neurons.
Besides PCs, recent studies have shown that under certain
conditions, adult striatal parenchymal NG2-positive glial cells—
i.e., oligodendrocytes precursors cells (OPCs)—are also able to
generate neuronal progeny. Genetic fate mapping of individual
DCX-positive cells present in the damaged parenchyma has
revealed that some are of NG2+-glial origin. Furthermore,
overexpression of Sox2 is sufficient to induce the conversion
of genetically fate-mapped NG2+ glia into DCX+ cells in the
adult mouse cerebral cortex following stab wound injury in vivo
(Heinrich et al., 2014). Finally, it has also been demonstrated in
situ in the brain that striatal NG2+ cells, transfected with Ascl1,
Lmx1a and Nurr1, can be reprogammed into functional neurons
that integrate into the local circuitry (Torper et al., 2015).
Unexpectedly, reactive astrocytes generated following stroke
also appear to be an important source of endogenous cells
that aid recovery. Although parenchymal astrocytes do not
divide in the healthy brain and do not form neurospheres
in vitro, the behavior of these cells drastically changes following
brain injury. Following stroke, two types of reactive astrocytes
have been identified: 1/reactive elongated astrocytes, which
incorporate BrdU and express progenitor markers such as
SOX2 and brain lipid binding protein (BLBP), and 2/stellate
astrocytes that derive from resident cortical astrocytes (Wanner
et al., 2013). A proportion of these reactive astrocytes has
the potential to self-renew and is multipotent in vitro (Lang
et al., 2004). Moreover, in addition to the conversion of local
parenchymal astrocytes, it has been shown that a subpopulation
of reactive the astrocytes generated following stroke is SVZ-
derived and contributes to the astrocyte scar (Benner et al.,
2013).
The ability of reactive astrocytes to generate neurons also
depends on their location. Genetic and viral lineage tracing
studies have reported the generation of neurons from reactive
striatal astrocytes following MCAO (Magnusson et al., 2014;
Duan et al., 2015). Conversely, there is a lack of evidence for a
direct in vivo neurogenic potential of these reactive astrocytes
in the cortex, probably due to anti-neurogenic influence.
Nevertheless, a latent neurogenic program is present in cortical
astrocytes. Indeed, a recent study has shown that SVZ-derived
NSCs are able to give rise to reactive astrocytes at the stroke site
and can be converted to neurons in vivo following overexpression
of Ascl1 (Faiz et al., 2015).
The capacity for parenchymal cells—as pericytes, NG2-
positive OPCs and reactive astrocytes—to give rise to neurons
following stroke opens new perspectives for their use as a repair
tool for brain regeneration.
Molecular Cues
Spontaneous recovery following stroke may come 1/from
the capacity of endogenous stem cells to proliferate into
neurogenic niches, migrate toward the damaged parenchyma,
and differentiate into neurons or 2/from parenchymal cells that
proliferate, dedifferentiate into neuronal cells and survive to
replace dead neurons. Understanding the molecular mechanisms
regulating these processes is necessary to improve brain recovery.
If neurogenic niches are a potent reservoir of NSCs that are
activated following stroke, how these cells are instructed to
proliferate and migrate long distances, far from the ischemic
parenchyma, remains an open question (Figure 2).
Neurogenic niches
Proliferation. The initial response of NSCs following stroke is
to increase proliferation, a process that is regulated by different
environmental and molecular cues. Indeed, following stroke,
the neurovascular unit combines with astrocytes, microglia and
others mediators to create a favorable environment for NSCs
proliferation in the neurogenic niches.
• Neurovascular regulation
Stroke induces dramatic changes in the vasculature (Sawada
et al., 2014) and increases angiogenesis, defined as the formation
of new capillaries from pre-existing vessels, suggesting a link
between stroke-induced neurogenesis and blood vessels (Ruan
et al., 2015). Following MCAO, reactive angiogenesis remodels
the disrupted blood vessel network in the injured striatum,
during a period of several days to 2 weeks after ischemia (Thored
et al., 2007). Angiogenesis is found in the penumbra of the brain
infarcted region in both animal models of stroke and in patients,
and a positive correlation exists between survival and the density
of new microvessels (Krupinski et al., 1994; Hayashi et al., 2003;
Ruan et al., 2015).
This neo-angiogenesis leads to vasculature and blood flow
changes. As a consequence, the levels of metabolic and
gas molecules are either increased (ATP) (Suyama et al.,
2012), or decreased (NO and O2) (Matarredona et al., 2005;
Panchision, 2009) around the blood vessels, and this regulates
the proliferation of adjacent NSCs (Lacar et al., 2012).
Moreover, fluid dynamics can also regulate the active transport
of blood-derived factors, such as insulin growth factor- 1
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FIGURE 2 | Regulation of stroke-induced neurogenesis in a standard neurogenic niche. In the healthy brain, adult neural stem cells (Dark green) present in
neurogenic niches contact blood vessels, proliferate and give rise to neuroblasts migrating from the SVZ to the olfactory bulb or from an other neurogenic niche to the
local parenchyma (upper panel). Following stroke, reactive astrocytes, activated microglia, and endothelial cells release chemokines and growth factors able to reach
neurogenic niches, increasing NSCs proliferation and attracting migrating neuroblasts to the ischemic area. Moreover, reactive astrocytes, NG2+ cells and pericytes
are able to dedifferentiate into neurons inside the damaged parenchyma (lower panel; Hermann et al., 2014; Sawada et al., 2014).
(IGF-1), to control adult SVZ neurogenesis (Nishijima et al.,
2010). Consistent with the important role of angiogenesis in
the regulation of stroke-induced NSC proliferation, blocking
post-ischemic angiogenesis results in a 10-fold reduction in
neuroblasts in the peri-infarct cortex 7 days after stroke (Ohab
et al., 2006). Finally, angiogenesis leads to changes in the
expression of growth factors, chemokines andmetalloproteinases
that can induce NSCs proliferation. Indeed, activated endothelial
cells in the ischemic area secrete VEGF, which promotes NSCs
proliferation and neuronal differentiation (Jin et al., 2002; Shen
et al., 2004). In response to the ischemic injury, endothelial cells
also secrete BDNF, erythropoietin, IGF-1, and FGF-2, which have
been shown to significantly increase progenitor cell proliferation
in both the SVZ and SGZ (Wiltrout et al., 2007). Interestingly,
in the SVZ, NSCs are able to promote angiogenesis by secreting
several angiogenic factors such as VEGFR2, Angiopoietin-1
and FGF-2 (Liu et al., 2007). This provides another strong
piece of evidence that links stroke-induced neurogenesis and
angiogenesis.
Besides angiogenesis, an important feature of neurogenic
niches regarding stroke-induced proliferation is their location.
Indeed, the majority of endogenous NSCs are directly or
indirectly in contact with the CSF and other critical factors.
In the SVZ, type B cells have direct access to the lumen of
the ventricles, and CVO stem cells are directly located along
the 3V and 4V. In contrast, the SGZ has no direct contact
with the ventricle, but the hippocampal sulcus (the groove
between the DG and CA1 field) could serve as a potential
point of access to CSF factors. Another common feature of
neurogenic niches is the rich network of blood vessels that
surround and communicate with stem cells. In the SVZ,
type B cells extend basal processes that terminate directly
on endothelial cells (Figure 2). Importantly, these vessels lack
the astrocyte endfeet and endothelial tight junctions that are
found elsewhere in the brain, resulting in a highly permeable
blood brain barrier (BBB) at the niche site (Shen et al., 2008;
Tavazoie et al., 2008). CVOs are often called the “windows
of the brain.” As a result, NSCs have access to both local
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endothelial cell-derived factors and systemic factors present in
the blood stream, including circulating cytokines, chemokines
and growth factors that all participate in adult neurogenesis
(Goldberg and Hirschi, 2009; Lin and Iacovitti, 2015). Indeed,
in physiological conditions, capillaries in the SVZ are known to
be permeable to diffusible molecules released from endothelial
cells, such as VEGF and pigment epithelium-derived factor
(PEDF), which regulate NSCs proliferation (Jin et al., 2002;
Andreu-Agulló et al., 2009). Moreover, adult NSCs express
integrins (alpha6 beta1 and alphaVB8), which serve as receptors
for laminin and TGFβ present within the vascular basement
membranes. Activation of these pathways in endothelial cells
leads to the production of growth factors that are necessary for
NSC survival and function (Shen et al., 2008; Mobley et al.,
2009). Moreover, growth factors, or reagents that stimulate
their expression, increase stroke-induced SVZ neurogenesis,
and conversely stroke-induced neurogenesis is impaired when
growth factors concentrations are decreased (Chen et al., 2005;
Tsai et al., 2006; Yan et al., 2006).
• Other regulators
In neurogenic niches, microglia are abundant and in close
contact with adult NSCs. Microglia activated after ischemic brain
injury are also able to produce chemokines and cytokines that
aid NSCs proliferation (Gonzalez-Perez et al., 2010; Yenari et al.,
2010). Notably, activated microglia are able to secrete IGF-1 to
promote NSCs proliferation in both of the classical neurogenic
niches (Hwang et al., 2004; Thored et al., 2009). Consistent with
this, inhibition of microglial activation after cerebral ischemia
decreases stroke-induced proliferation in the SVZ (Kim et al.,
2009).
Finally, other potential mediators of stroke-induced
proliferation neurogenesis—mainly in the classical neurogenic
niches—have been described. These include Notch signaling
(Wang et al., 2009), retinoic acid (Plane et al., 2008), bone
morphogenetic protein (Chou et al., 2006), tumor necrosis
factor-alpha (Iosif et al., 2008), and sonic hedgehog (Sims et al.,
2009). Besides chemokines and soluble factors, other regulators
of SVZ and DG stem cell proliferation have been described, such
as microRNA (Liu et al., 2013), exercise (Luo et al., 2007), and
electroacupuncture (Kim et al., 2014).
Migration. Following NSCs proliferation, the next step following
stroke is the production of new neurons in the injured region.
Indeed stroke can induce long-distance cell migrations of newly
born immature neurons to the peri-infarct cortical area (Tsai
et al., 2006; Yamashita et al., 2006). Studies have shown that
following BrdU or GFP lentiviral injections into the SVZ at the
time of stroke, labeled cells are detected in peri-infarct cortex at
7 and 14 days post stroke, whereas injections of BrdU directly
into the cortex results in only a few BrdU+/DCX+ cells. Several
critical regulators of newborn cells following stroke have been
identified over the years.
• Vascular regulation
Similar to the regulation of stroke-induced NSCs
proliferation, the vascular environment is also a key
feature regarding the migration of newborn cells following
stroke.
• Scaffold cues
During embryonic development and early postnatal stages,
coordinated neurogenesis and angiogenesis are important
(Sawada et al., 2014). Indeed, at the neonatal stage, SVZ-derived
newborn cells migrate along blood vessels not only to the OB
but also to the cerebral cortex (Le Magueresse et al., 2012). This
blood vessel-guided cell migration toward the cerebral cortex
gradually decreases during postnatal development, probably due
to a decrease in blood vessel density in the corpus callosum (Le
Magueresse et al., 2012). Following stroke, this developmental
cell migration toward the cortex is reactivated, and chains of
neuroblats migrate in the direction of the damaged parenchyma,
along the blood vessels away from both the classical and novel
niches (Pencea et al., 2001; Sawada et al., 2014; Lin et al., 2015).
Post-stroke neuroblast migration toward the injured region
shares characteristic features with physiological neuroblast
migration within the RMS. In both cases, neuroblasts form
chain-like cell aggregates (Arvidsson et al., 2002; Parent
et al., 2002; Yamashita et al., 2006) and migrate along blood
vessels (Zhang and Chopp, 2009; Kojima et al., 2010; Saha
et al., 2013). After stroke, during the blood vessel-guided
migration, newborn neuroblasts are frequently associated with
thin astrocytic processes (Jin et al., 2003; Thored et al., 2006;
Yamashita et al., 2006; Kojima et al., 2010), which directly
contact vascular endothelial cells (Le Magueresse et al., 2012),
forming a neurovascular niche. Double labeling for BrdU and
PECAM-1 confirms that blood vessels in the peri-infarct cortex
contain newly born vascular endothelial cells (Lacar et al., 2012).
Moreover, inhibiting angiogenesis decreases the number of new
neurons in injured regions (Taguchi et al., 2004; Ohab et al.,
2006; Cayre et al., 2013), suggesting that newly generated blood
vessels play a role in neuronal regeneration. Since new neurons
migrate along both pre-existing and newly generated blood
vessels after MCAO, both old and new blood vessels appear to
act as a migratory scaffold for new neuroblasts moving toward
injured regions (Kojima et al., 2010; Grade et al., 2013). Thus,
remodeling the blood vessel network in injured regions and
regulating the direction of new neuron migration could improve
the efficiency of blood vessel-guided neuronal migration and
neuronal regeneration.
• Guidance cues
Besides their role as scaffolds, endothelial cells are also
able to secrete several factors that regulate the migration of
neuroblasts, both in normal and pathological conditions. During
adult neurogenesis, stromal-derived factor-1α (SDF-1α), a CXC
chemokine, is secreted by vascular endothelial cells and enhances
the motility of neuroblasts, which express its receptor CXR4,
toward the RMS (Kokovay et al., 2010). Similarly, following
stroke, endothelial cells and reactive astrocytes upregulate SDF-1
(Ohab et al., 2006; Thored et al., 2006), which guides neuroblast
migration toward the peri-infarct region (Robin et al., 2006).
Administration of SDF-1 improves behavioral recovery during
the period in which immature neurons migrate (Ohab et al.,
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2006), whereas blockade of CXRC4 with the specific antagonist
AMD3100 alters the migration of new neurons in vitro and
in vivo (Robin et al., 2006; Thored et al., 2006; Kojima et al., 2010).
• Astrocytes/microglia
Activated astrocytic and microglial populations in the core
and the penumbra produce several factors, including cytokines
and chemokines, which may act as putative chemoattractants
for proliferating progenitors. For example, the expression of
monocyte chemoattractant protein-1 (MCP-1), a CC chemokine,
is induced in activated microglia and astrocytes after MCAO,
while migrating neuroblasts express the MCP-1 receptor CCR2
(Cayre et al., 2013). Furthermore, MCP-1 and CCR2 KO mice
display a significant decrease in the number of migrating
neuroblasts from the ipsilateral SVZ to the ischemic striatum
(Yan et al., 2007).
• Other regulators
Matrix metalloproteinases (MMPs) are expressed by
endothelial cells following stroke, and digest the extracellular
matrix to enable migrating newborn cells to penetrate the
damaged parenchyma. MMPs have been implicated in guiding
neuroblast migration from the neurogenic region to the ischemic
boundary (Grade et al., 2013). MMP9 is upregulated in the
infarcted cortex and co-localizes with DCX+ and BrdU+ cells
migrating from SVZ. Moreover, blocking the activation of MMPs
severely diminishes striatal migration (Lee et al., 2006; Barkho
et al., 2008).
Non-neurogenic niches
As discussed above, neurogenesis also occurs in the damaged
parenchyma. However, it seems that an anti-neurogenic
environment prevents reactive astrocytes from becoming
neurons. A more complete understanding of the molecular
mechanisms that determine gliogenesis vs. neurogenesis is
important to increase the number of newborn neurons in the
injured area. Notably, the oligodendrocyte transcription factor
OLIG2 and the neurogenic paired-box protein PAX6 are both
potent regulators of stroke-induced neurogenesis. Stereotaxic
retroviral injection of either a dominant negative form of Olig2,
or a PAX6 overexpression construct, in the lateral striatum of
MCAO rat brains results in a significant increase in the number
of DCX-expressing immature neurons (Kronenberg et al., 2010;
Robel et al., 2011). In addition, inhibition of Notch signaling—a
strong anti-neurogenic pathway—triggers astrocytes in the
striatum and the medial cortex to enter a neurogenic program,
even in physiological conditions (Magnusson et al., 2014).
Moreover, TNF-α or noggin—a bone morphogenetic protein
(BMP) inhibitor—can modulate the latent neurogenic capacity
of parenchymal astrocytes (Michelucci et al., 2015). Therefore,
modulating the fate of endogenous parenchymal astrocytes
represents an interesting target to induce neurogenesis after
stroke.
Functional Impact
Several recent studies have shed light on the essential role of
stroke-induced neurogenesis on functional recovery. Consistent
with the neuroprotective role of NSCs, targeted depletion of both
DCX- or Nestin-expressing cells in the SVZ has been linked
to worsened stroke lesion size and motor impairment (Wang
et al., 2012; Sun et al., 2013). On the contrary, manipulations
aimed at increasing neurogenesis have been shown to improve
functional outcomes (Leker et al., 2007). In endothelin-induced
stroked rats, a combined treatment of fluoxetine, simvastatin and
ascorbic acid produces a significant increase in neurogenesis,
which is coupled to a strong functional recovery (Corbett et al.,
2015). In ischemic mice brains, post-stroke chronic metformin
treatment has been shown to enhance angiogenesis, neurogenesis
and improve functional recovery following MCAO (Jin et al.,
2014). These studies establish a clear link between stroke-induced
neurogenesis and functional recovery. However, it is not yet
understood why spontaneous endogenous neurogenesis does
not lead to a complete recovery. Many milestones have to be
reached in order to obtain functional recovery following stroke.
Appropriate differentiation, long-term production and survival
of stroke-induced newborn neurons, as well as the inflammatory
response, are all potential restrictive characteristics regarding
stroke recovery.
Differentiation and integration of newborn neurons
In order to contribute to functional recovery, nascent neurons,
coming from non-neurogenic regions or neurogenic niches,
must mature both morphologically and functionally. Early
work showed that newly generated cells in the damaged
striatum express markers of medium-size spiny neurons like
DARPP-32, representing 95% of neurons within the striatum
(Arvidsson et al., 2002; Parent et al., 2002). More recently,
newborn cells, following focal cerebral ischemia, have also been
shown to express appropriate neurotransmitter synthesizing
enzymes such as glutamic acid decarboxylase (GAD67) and
choline acetyl-transferase (ChAT). Moreover, these neurons
exhibit electrophysiological activity and functional synapses
(Hou et al., 2008). These data suggest that stroke-induced
newborn GABAergic and cholinergic neurons can integrate into
the striatal neural networks. However, if about 90–95% of striatal
neurons are GABAergic medium-size spiny projection neurons,
5–10% of the remaining neurons are local interneurons that
are classically divided into parvalbumin+ (PV+), calretinin+
(CR+), somatostatin+ (SOM+), and choline acetyltransferase+
(ChAT+) neurons (Marin et al., 2000). Immunostainings
performed against these different markers, coupled with BrdU
labeling, have shown that SVZ neuroblasts can produce CR-
expressing newborn cells in the damaged striatum (Liu et al.,
2009). Finally, another study has shown that newly born
immature neurons differentiate into mature PV-expressing
neurons, replacing more than 20% of PV+ interneurons lost
after ischemia (Teramoto et al., 2003). Taken together, these
data indicate that proliferating neuroblasts that migrate into the
damaged striatum following stroke are able to differentiate into a
variety of functional neuronal cells.
Long-term survival/production of newborn neurons
The long-term survival of newly-formed neurons following
stroke is also crucial for a successful functional recovery.
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Although recent work indicates that new neurons persist for at
least 3–4 months after stroke (Thored et al., 2006; Leker et al.,
2007), survival of newly generated cells is inefficient (Turnley
et al., 2014). Only 10% of the initial number of neuroblasts
that migrate to the peri-infarct cortex express mature neuronal
markers (Gu et al., 2000; Dempsey et al., 2003), while 6 weeks
after ischemia, one third of DCX+/BrdU+ cells express mature
neuronal markers (Thored et al., 2006). Moreover, many of
these DCX+ cells co-expressing cPARP, a substrate of active
caspases, which suggests there is widespread apoptosis within
the DCX+ cell population (Thored et al., 2006). Taken together,
these data indicate that only a small proportion of cells survive
long enough to integrate into the damaged parenchyma. This
may be linked to an inappropriate inflammatory response
in the ischemic area that is deleterious for newborn neuron
survival. In support of this, treatment with indomethacin, a
non-steroidal anti-inflammatory agent, suppresses inflammation
and microglial activation, and stimulates the accumulation of
newborn neurons in the injured striatum following MCAO in
adult rats (Hoehn et al., 2005). Moreover, up-regulation of TNFα
expression following stroke has been shown to decrease SVZ
progenitor proliferation, whereas blockade of TNF receptor-1
signaling has been demonstrated to increase stroke-induced SVZ
cell proliferation and neuroblast formation (Iosif et al., 2008).
Initial studies suggested that increased SVZ neurogenesis is
transient, as progressive recovery of certain behavioral deficits
does not continue beyond 1 month. However, BrdU injections
have shown a similar proportion of DCX+/BrdU+ at either
at 2 or 8 weeks post-ischemia (Thored et al., 2006). Moreover,
the migration of SVZ neuroblasts to the injured striatum may
persist for up to 1 year after ischemia (Thored et al., 2007),
suggesting that the SVZ may serve as a constant reservoir
of new neurons offering a long-term window for therapeutic
manipulations.
CONCLUSION
Besides rtPA treatment, there is an urgent need to develop new
treatments for stroke that are aimed at ultimately replacing dead
neurons. While exogenous stem cell therapy presents interesting
outcomes, increasing endogenous neurogenesis constitutes the
most promising therapeutic strategy. Indeed, the presence of
multiple pools of endogenous adult neuroblasts that are able to
proliferate, migrate and differentiate, offers multiple possibilities
for interventions. These strategies require that the as yet
unknown molecular mechanisms that instruct stem cells to
differentiate into specific neuronal cell types will also work in
the brain of the affected individual. For maximum functional
recovery, transplantation should probably be combined with a
stimulation of neurogenesis from endogenous NSCs.
However, several critical questions have to be addressed
before clinical trials can begin. Optimization of the timing and
treatment is required, along with the identification of factors
that give the most favorable survival and function of new
cells, irrespective of their exogenous or endogenous origin. In
addition, the heterogeneity among stroke patients constitutes an
important challenge. The use of clinically relevant experimental
animal models is essential, since numerous successful preclinical
trials have failed to confirm their efficacy upon translation to
humans. Moreover, inflammation is increasingly recognized as a
key factor in stroke, but whether it is detrimental or beneficial
depends on the severity and stage of the ischemia. It appears
that an inflammatory response during the early stages of stroke
potentiate ischemic injury, while late inflammation appears to be
important for recovery and repair. Future work should focus on
elucidating how the immune systemmoves from these damaging
to protective/restorative responses. Consequently, a nuanced
modulation of inflammation may lead to improved exogenous
and endogenous potentiality regarding stroke recovery.
Elucidating the molecular mechanisms that regulate
endogenous neurogenesis in stroke can be extended to other
neurodegenerative diseases. Indeed, despite different triggering
events, a common feature of neurodegenerative disease is
neuronal cell death and immune responses.
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